The concept of innovative drugs remains active, with Xintian Pharma and others hitting the daily limit

The concept of innovative drugs continues to be active, with Xintian Pharma, Fuyuan Pharmaceutical, CheezhengTTM, JLPC, and HSGC hitting the daily limit, Guanhao Biotech rising over 13%, and ALK increasing over 9%

The infant and assisted reproduction concepts continue to be strong, with Sunshine Dairy and other stocks hitting the limit up

In the morning session, the baby and child, as well as assisted reproduction concepts continued to be strong, with Sunshine Dairy and Anzheng Fashion achieving three consecutive trading limits. Goto Biopharm and HSGC hit the daily limit, while DAJIAWEIKANG, Beingmate, Jinma Amusement, and Qianyuan Pharmaceutical saw significant gains

The A-share innovative drug concept continues to be strong, with YABAO PHARM.CORP hitting the limit up, and JENKEM, HSGC, YKYY, MEDISAN, HITECK, and others leading in gains

AH shares rose in the morning! The three major stock indices collectively increased, with strong activity in consumer sectors. The Hang Seng Index and the Hang Seng Tech Index surged, innovative drugs exploded, while commodities and government bonds showed divergence

A-share innovative drug concept stocks remain strong, WECOME hit the 20% limit up, Chengdu XianDao rose over 10%, Lishengpharma and HSGC hit the limit up, Boji Pharmaceutical, Anglikang, Thalys, Shenzhou Cell, Mabwell, Fudan Zhangjiang and other stocks rose over 5%. Hong Kong stock biopharmaceutical stocks strengthened at the beginning of the session, Kangfang Biotech once rose over 10%, Kelun-B rose over 6%, Baiji Shenzhou rose over 5%, Genscript Biotech, Tigermed and others rose over 4%

Retail stocks fluctuate and rise

INZONE GROUP surged to the daily limit in the closing hours, with CCEG, ZSCBGCL, DFGC, YIWU CCC, and HSGC also following suit